Prediction of pathological response using 18F FDG PET/CT derived metabolic parameters in locally advanced breast cancer patients.

Aim Of Work: This study aims to assess the value of flurodeoxyglucose (FDG)-PET derived metabolic parameters for prediction of pathologic response in LABC postneoadjuvant therapy.

Methods: Totally 47 patients with LABC underwent initial and postneoadjuvant therapy PET scans. ΔSUVmax%, ΔTLG% and ΔMTV% were calculated.